Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
Diagnosis and treatment of hyponatraemia.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Cost-utility of fingolimod compared with dimethyl fumarate in highly active relapsing-remitting multiple sclerosis (RRMS) in England.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome.
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
CXCR7 Is Involved in Human Oligodendroglial Precursor Cell Maturation.
Reduction of CD8(+) T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate.
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.
Dimethyl fumarate suppresses Theiler's murine encephalomyelitis virus - induced demyelinating disease by modifying Nrf2-Keap1 pathway.
Risk factors for convertion to clinically defined multiple sclerosis after clinically isolated syndrome in a racially mixed Brazilian cohort.

Pages